-+ 0.00%
-+ 0.00%
-+ 0.00%

Pacira urges vote for board slate as DOMA seeks to replace three director nominees ahead of June 9 meeting

PUBT·05/27/2026 20:23:26
Listen to the news
Pacira urges vote for board slate as DOMA seeks to replace three director nominees ahead of June 9 meeting
  • Pacira faces a proxy fight ahead of its June 9 annual meeting, challenged by DOMA Perpetual Capital Management seeking to replace three board nominees.
  • Management urged investors to vote the blue proxy card for its slate: Christopher Christie, Samit Hirawat, Thomas Wiggans.
  • Pacira argued DOMA’s nominees lack relevant experience, citing 17 engagement meetings since September 2023 and incomplete nominee interviews.
  • The company pointed to 2025 results to support its strategy, including record revenue of $726.4 million and GAAP net income of $7 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pacira Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605271620PRIMZONEFULLFEED9727654) on May 27, 2026, and is solely responsible for the information contained therein.